Keep it real
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks, but no not really.
Still await company news. Waiting for over a year on PK/PD.
What about the poison pill ?
What about PK/PD ?
What about P2/3 AD trial start ?
What about trial funding ?
Thanks for attending!
No he has not.
Fait accompli
Dead lock
Really?
How many biotech have claimed the crown in the past??
Perhaps, we do not know.
It is still an uncertainty.
You assume that the Australian government and MJFF will sponsor the trial.
Rett foundation funds 60%
It feels like writing a giant blanc cheque and hoping for the best.
No more stop losses on AVXL?
Perhaps. Time will tell.
Yes: the intention was never there to present it, but the abstract title was a communication to shareholders that all is good, just as in June 2015 with his daily purchase plan. No SEC rules violated and stil word is out.
Remember it was never officially announced.
To expect 12 week trial result on Rett and/or Parkinson by end 2017 leads to an automatic deduction that trial initiation will have to be prior the end of 2017.
Because..... ?
Trial n = 32
And you wanna fund a 4th trial with it?
No he has not.
How would you fund it?
SO EXCITED!
are doing GREAT! COntinuing their uptrend from 53 weeks..and rocking it out..
Obviously the 6 super responders are continuing on an UNCHARTERED..
UNBELIEVABLE, MIRACULOUS course..
UNHEARD, NEVER BEFORE SEEN..CURATIVE of all SYMPTOMATIC..and maybe even
Given yesterdays ruling, I would no longer consider a MS-loser. Then again a prudent company would use that time to prepare the mid-term future and thats were Anavex could help out.
That is if the testing of 2-73 is sucessfull. So far all we have is radio silence.
Whatever theory one prefers.
no facts support it.
I say again:
no need to raide cash,
26 mil on hand,
DOD paying for 2 phase 2 trials,
...
There is no offerening
There is no need for cash
26 mil on hand
2 phase trials paid by DOD
As solid as the run last July to $8 and the subsequent fall to $3?
I can understand this would be abandoned as there is not real live data backing up the scientific hypothesis.
3) MaCFarlane no longer employed
THEIR STATED PLANS HAVE TURNED OUT EXACTLY AS THEY SAID THEY WOULD
Interesting webcast last night. Pretty obvious that financing is currently not a concern.
Latest trial is again funded by the DOD.
Ofcourse, know the world knows what this board has known for 2 weeks: another DOD grant.
Disagree, nothing new. This board has known about the grant at least 2 weeks.
Value for shareholders will come from trial data, not PR-releases. Three P2-trials running.
Excellent observation!
Possible, time will tell.
Historically, the share price runs up into data and drops like a brick on good news due MM's
Any proof for that "extremely loyal retail" ??
I thought we were gonna end above $8 last week?
Wrong: run up to $14 end October 2015, run up to $8 end July 2016
Keyword being "should"
Since when does Anavex shareprice react positively on good scientific data? All evidence so far indicates the opposite.
Perhaps major news can break it. E.g. Partnership, FDA approval,...
Welcome to iHub.
Please provide a source to your statement.
Green it is.
Rather pointless predicting the outcome of binary events.
well, thats a 50-50 chance. Who knows, time will tell.
I must be colorblind as I am seeing green. Strange
Article is paid promotion
Check the disclaimer
2016 MicrocapResearch Fee Disclosure:
Received $10,000 from unrelated third party to raise investor awareness in TapImmune Inc. (TPIV)
2017 MicrocapResearch Fee Disclosure:
Received $10,000 from an unrelated third party to raise investor awareness in TapImmune Inc. (TPIV)